Roche partners with RNA editing biotech Ascidian - Yahoo Finance

Retrieved on: 2024-06-18 15:13:34

Tags for this article:

Antisense RNA

Roche

Ionis Pharmaceuticals

RNA

Molecular biology

Click the tags to see associated articles and topics

Roche partners with RNA editing biotech Ascidian - Yahoo Finance. View article details on hiswai:

Summary

Roche’s collaboration with Ascidian Therapeutics focuses on developing RNA exon editing drugs to enhance its neurology pipeline, aligning with biopharma trends and addressing issues in direct DNA editing. This complements Roche's previous RNA-related deals, including those with Ionis Pharmaceuticals.

Article found on: finance.yahoo.com

View Original Article